<!DOCTYPE HTML PUBLIC "">


<HTML>
<HEAD>
   <TITLE> -- Converted by SECPublisher 3.1.0.1, created by BCL Technologies Inc., for SEC Filing</TITLE>
   <META name="HandheldFriendly" content="true">
</HEAD>

<BODY bgcolor="#ffffff">


<A name="page_1"></A>

<TABLE border=0 cellspacing=1 cellpadding=0>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">SECURITIES AND EXCHANGE COMMISSION</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">Washington, D.C. 20549</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">FORM S-8</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD width=99% nowrap align=center>
<B><FONT size=2 face="serif">REGISTRATION STATEMENT under THE SECURITIES ACT OF 1933</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">Medical International Technology, Inc.</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(Exact name of registrant as specified in charter)</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">Colorado</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(State or other jurisdiction of incorporation or organization)</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">84-1509950</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(IRS Employer Identification No.)</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD width=99% nowrap align=center>
<B><FONT size=2 face="serif">2281 Guenette, Ville Saint-Laurent Montreal, Quebec, Canada HR4 2E9</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(Address of principal executive offices and Zip Code)</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">Compensation</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(Full title of the plan)</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD width=99% nowrap align=center>
<B><FONT size=2 face="serif">Karim Menassa, 2281 Guenette, Montreal, Quebec, Canada HR4 2E9</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(Name and address of agent for service)</FONT>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<B><FONT size=2 face="serif">(514) 339-9355</FONT></B>
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center width=100%>
<FONT size=2 face="serif">(Telephone number of agent for service)</FONT>
	</TD>
</TR>
</TABLE><BR>
<TABLE border=0 cellspacing=1 cellpadding=0>
<TR valign="bottom">
	<TD align=center width=100% colspan=9>
<B><FONT size=2 face="serif">CALCULATION OF REGISTRATION FEE</FONT></B>
	</TD>
</TR>
<TR>
	<TD colspan=9 width=100%>
<HR noshade size=1>
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">Proposed</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">Title of each class of</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=center>
<FONT size=2 face="serif">Proposed</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=center>
<FONT size=2 face="serif">Amount of</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=center>
<FONT size=2 face="serif">Amount to be</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">maximum</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">securities to be</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=center>
<FONT size=2 face="serif">maximum offering</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=center>
<FONT size=2 face="serif">registration</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=center>
<FONT size=2 face="serif">registered</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">aggregate offering</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">registered</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=center>
<FONT size=2 face="serif">price per share</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=center>
<FONT size=2 face="serif">fee</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=center>
<FONT size=2 face="serif">price</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=21% nowrap align=center>
<B><FONT size=2 face="serif">Common Shares</FONT></B>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=16% nowrap align=center>
<B><FONT size=2 face="serif">750,000</FONT></B>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=20% nowrap align=center>
<B><FONT size=2 face="serif">&#36;0.40</FONT></B>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=21% nowrap align=center>
<B><FONT size=2 face="serif">&#36;300,000</FONT></B>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=center>
<B><FONT size=2 face="serif">&#36;</FONT></B><FONT size=2 face="serif">38.01</FONT>&nbsp;
	</TD>
</TR>
<TR>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
<HR noshade size=1>
	</TD>
</TR>
</TABLE><BR>
<P>
<FONT size=2 face="serif">Note: Proposed maximum offering price per share and Proposed maximum aggregate offering price estimated solely for the purpose of calculating the registration fee pursuant to Rule 457. </FONT></P>
<P>
<B><FONT size=2 face="serif">PART I </FONT></B></P>
<P>
<B><FONT size=2 face="serif">INFORMATION REQUIRED IN THE PROSPECTUS </FONT></B></P>
<P>
<FONT size=2 face="serif">Note: The document(s) containing the information concerning the Medical International Technology Stock Option Agreement dated October 1, 2005, with Geoffrey Armstrong for services, to Medical International Technology, Inc.,
a Colorado corporation (the "Registrant" or the "Company"), required by Item 1 of Form S-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the statement of availability of registrant information, employee benefit plan
annual reports and other information required by Item 2 of Form S-8 will be sent or given to participants as specified in Rule 428. In accordance with Rule 428 and the requirements of Part I of Form S-8, such documents are not being filed with the
Securities and Exchange Commission (the "Commission") either as part of this registration statement on Form S-8 (the "Registration Statement") or as prospectuses or prospectus supplements pursuant to Rule 424. The Company will maintain a file of
such documents in accordance with the provisions of Rule 428. Upon request, the Company shall furnish to the Commission or its staff a copy or copies of all of the documents included in such file. </FONT></P>
<P>
<FONT size=2 face="serif">1 </FONT></P>

<HR noshade align="center" width="100%" size=2>


<A name="page_2"></A>

<P>
<B><FONT size=2 face="serif">PART II </FONT></B></P>
<P>
<B><FONT size=2 face="serif">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT </FONT></B></P>
<P>
<B><FONT size=2 face="serif">Item 3. Incorporation of Documents by Reference. </FONT></B></P>
<P>
<FONT size=2 face="serif">The following documents, which have been filed by the Company with the Securities and Exchange Commission, are hereby incorporated by reference: </FONT></P>
<P>
<FONT size=2 face="serif">a. The Company's Annual Report on Form 10-KSB for the fiscal year ended September 30, 2004; </FONT></P>
<P>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">b. The Company's Quarterly Reports on Form 10-QSB for the fiscal quarters ended December 31, 2004, March 31, 2005, June 30, 2005. </FONT></P>
<P>
<FONT size=2 face="serif">All documents filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective
amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated in this Registration Statement by reference and
to be a part hereof from the date of filing of such documents. </FONT></P>
<P>
<FONT size=2 face="serif">Any statement contained in this Registration Statement, in a supplement to this Registration Statement or in a document incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a statement contained herein or in any subsequently filed supplement to this Registration Statement or in any document that is subsequently incorporated by reference herein modifies or supersedes such
statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement. </FONT></P>
<P>
<B><FONT size=2 face="serif">Item 4. Description of Securities. </FONT></B></P>
<P>
<FONT size=2 face="serif">The Company's authorized capital consists of 100,000,000 shares of Common Stock, &#36;0.0001 par value and 3,000,000 shares of Preferred stock, par value &#36;0.001, of which 9,341,435</FONT><FONT face="sans-serif">
</FONT><FONT size=2 face="serif">common shares were outstanding as of December 9, 2005. No Preferred shares have been issued. </FONT></P>
<P>
<FONT size=2 face="serif">The Company's common stock is presently listed and traded on the NASD Over-The-Counter Bulletin Board exchange under the symbol "MDIR".</FONT></P>
<P>
<B><FONT size=2 face="serif">Common Stock </FONT></B></P>
<P>
<FONT size=2 face="serif">Each share of Common Stock is entitled to one vote, either in person or by proxy, on all matters that may be voted upon by the owners thereof at a meeting of the shareholders, including the election of directors. The
holders of Common Stock (i) have equal, ratable rights to dividends from funds legally available therefore, when, as and if declared by the Board of Directors of the Company; (ii) are entitled to share ratably in all of the assets of the Company
available for distribution to holders of Common Stock upon liquidation, dissolution or winding up of the affairs of the Company; (iii) do not have preemptive or redemption provisions applicable thereto; and (iv) are entitled to one non cumulative
vote per share on all matters on which shareholders may vote at all meetings of shareholders. </FONT></P>
<P>
<FONT size=2 face="serif">All shares of Common Stock issued and outstanding are, and those offered hereby, when issued, will be fully paid and nonassessable, with no personal liability attaching to the ownership thereof. </FONT></P>
<P>
<FONT size=2 face="serif">2 </FONT></P>

<HR noshade align="center" width="100%" size=2>


<A name="page_3"></A>

<P>
<B><FONT size=2 face="serif">Transfer Agent </FONT></B></P>
<TABLE><TR><TD width=3>&nbsp;</TD><TD nowrap>
<FONT size=2 face="serif">Corporate Stock Transfer </FONT><BR>
<FONT size=2 face="serif">3200 Cherry Creek Road South, Suite 430 </FONT><BR>
<FONT size=2 face="serif">Denver, CO 80209 </FONT><BR>
</TD></TR></TABLE>
<P>
<B><FONT size=2 face="serif">Item 5. Interests of Named Experts and Counsel. </FONT></B></P>
<P>
<FONT size=2 face="serif">As of the date of this registration no named expert or counsel holds any specified interest or significant equity in the company.</FONT></P>
<P>
<B><FONT size=2 face="serif">Item 6. Indemnification of Directors and Officers. </FONT></B></P>
<P>
<FONT size=2 face="serif">The Company's Articles of Incorporation authorizes the Corporation to indemnify to the maximum extent permitted under Colorado law. </FONT></P>
<P>
<FONT size=2 face="serif">The Colorado Private Corporations Act allows indemnification of directors, officers, employees and agents of the Company, including the advancement of expenses: Every person who was or is a party or is threatened to be made
a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or a person of whom he is the legal representative is or was a director or officer of the
corporation or is or was serving at the request of the corporation for its benefit as a director or officer of another corporation, or as its representative in a partnership, joint venture, trust or other enterprise, shall be indemnified and held
harmless to the fullest extent legally permissible under the general corporation law of the State of Colorado from time to time against all expenses, liability and loss (including attorney's fees, judgments, fines, and amounts paid or to be paid in
settlement) reasonably incurred and in advance of the final disposition of the action, suit or proceeding upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of
competent jurisdiction that he is not entitled to be indemnified by the corporation. Such right of indemnification shall be a contract right which may be enforced in any manner desired by such person; and shall not be exclusive of any other right
which such directors, officers or representatives may have or hereafter acquire and, without limiting the generality of such statement, they shall be entitled to their respective rights of indemnification under any bylaw, agreement, vote of
stockholders, provision of law or otherwise, as well as their rights under the Articles of Incorporation of Medical International Technology, Inc.. </FONT></P>
<P>
<FONT size=2 face="serif">In general, officers and directors of Registrant are indemnified against expenses actually and reasonably incurred in connection with proceedings, whether civil or criminal, provided that it is determined that they acted in
good faith, and are not deemed to be liable to Registrant for negligence or misconduct in the performance of their duties. </FONT></P>
<P>
<B><FONT size=2 face="serif">Item 7. Exemption from Registration Claimed. </FONT></B></P>
<P>
<FONT size=2 face="serif">Not Applicable. </FONT></P>
<P>
<FONT size=2 face="serif">3 </FONT></P>

<HR noshade align="center" width="100%" size=2>


<A name="page_4"></A>

<P>
<B><FONT size=2 face="serif">Item 8. Exhibits. </FONT></B></P>
<TABLE border=0 cellspacing=1 cellpadding=0>
<TR valign="bottom">
	<TD width=20% nowrap colspan=3 align=left>
<B><FONT size=2 face="serif">Exhibit Number</FONT></B>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=76% nowrap align=left>
<B><FONT size=2 face="serif">Description</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
<FONT size=2 face="serif">4.1</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Medical International Technology Consulting Agreement with Kouzelne Mesto Ltd., a</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Czech Republic Incorporated Company, beneficially owned as to 100% by Geoffrey</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Armstrong, and dated October 1, 2005.</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
<FONT size=2 face="serif">4.2</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Medical International Technology Stock Option Agreement with Geoffrey Armstrong</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">dated October 1, 2005.</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
<FONT size=2 face="serif">5.1</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Opinion of Counsel, Dieterich &amp; Associates</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
<FONT size=2 face="serif">23.1</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Consent of Certified Public Accountants</FONT>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=9% nowrap align=left>
<FONT size=2 face="serif">23.2</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=87% nowrap colspan=3 align=left>
<FONT size=2 face="serif">Consent of Dieterich &amp; Associates (included in Exhibit 5.1)</FONT>&nbsp;
	</TD>
</TR>
</TABLE><BR>
<P>
<B><FONT size=2 face="serif">Item 9. Undertakings </FONT></B></P>
<P>
<FONT size=2 face="serif">1.</FONT><FONT size=2 face="sans-serif"> </FONT><FONT size=2 face="serif">The Registrant hereby undertakes: </FONT></P>
<P>
<FONT size=2 face="serif">(a) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </FONT></P>
<P>
<FONT size=2 face="serif">(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; </FONT></P>
<P>
<FONT size=2 face="serif">(ii)to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the formation set forth in the registration statement; </FONT></P>
<P>
<FONT size=2 face="serif">(iii) to include any material information with respect to a plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </FONT></P>
<P>
<FONT size=2 face="serif">(b) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial bonafide offering thereof. </FONT></P>
<P>
<FONT size=2 face="serif">(c) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </FONT></P>
<P>
<FONT size=2 face="serif">2. The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange
Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement
relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be in the initial bona fide offering thereof. </FONT></P>
<P>
<FONT size=2 face="serif">4 </FONT></P>

<HR noshade align="center" width="100%" size=2>


<A name="page_5"></A>

<P>
<B><FONT size=2 face="serif">SIGNATURES </FONT></B></P>
<P>
<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Montreal, Quebec, Canada, on this 28th day of October, 2005. </FONT></P>
<P>
<FONT size=2 face="serif">Medical International Technology, Inc. </FONT></P>
<TABLE><TR><TD width=6>&nbsp;</TD><TD nowrap>
<FONT size=2 face="serif">/s/ Karim Menassa </FONT><BR>
<FONT size=2 face="serif">Karim Menassa </FONT><BR>
<FONT size=2 face="serif">President and CEO </FONT><BR>
</TD></TR></TABLE>
<P>
<FONT size=2 face="serif">In accordance with the requirements of the Securities Act of 1933 as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated. </FONT></P>
<TABLE border=0 cellspacing=1 cellpadding=0>
<TR valign="bottom">
	<TD width=27% nowrap align=left>
<FONT size=2 face="serif">SIGNATURE</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=42% nowrap align=left>
<FONT size=2 face="serif">TITLE</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
<FONT size=2 face="serif">DATE</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=2% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=5% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=27% nowrap align=left>
<FONT size=2 face="serif">/s/ Karim Menassa</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=42% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=2% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=5% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
</TR>
<TR valign="bottom">
	<TD width=27% nowrap align=left>
<FONT size=2 face="serif">Karim Menassa</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=42% nowrap align=left>
<FONT size=2 face="serif">Chief Executive Officer, President</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
<FONT size=2 face="serif">December</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=2% nowrap align=right>
<FONT size=2 face="serif">9,</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=5% nowrap align=right>
<FONT size=2 face="serif">2005</FONT>&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR>
	<TD colspan=9>
&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD width=27% nowrap align=left>
<FONT size=2 face="serif">/s/ Michel Bayouk</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=42% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=2% nowrap align=left>
&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=5% nowrap align=left>
&nbsp;
	</TD>
</TR>
<TR>
	<TD>
<HR noshade size=1>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
	<TD>
	</TD>
</TR>
<TR valign="bottom">
	<TD width=27% nowrap align=left>
<FONT size=2 face="serif">Michel Bayouk</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=42% nowrap align=left>
<FONT size=2 face="serif">Chief Financial Officer, Secretary</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=13% nowrap align=left>
<FONT size=2 face="serif">December</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=2% nowrap align=right>
<FONT size=2 face="serif">9,</FONT>&nbsp;
	</TD>
	<TD width=2%>
&nbsp;	</TD>
	<TD width=5% nowrap align=right>
<FONT size=2 face="serif">2005</FONT>&nbsp;
	</TD>
</TR>
</TABLE><BR>
<P>
<FONT size=2 face="serif">5 </FONT></P>

<HR noshade align="center" width="100%" size=2>

</BODY>

</HTML>
[{"type": "S-8", "sequence": "1", "filename": "mits8a.htm", "description": "FORM S8", "secsgml_size_bytes": 26064}, {"type": "S-8", "sequence": "2", "filename": "mits8a.pdf", "description": "FORM S8", "secsgml_size_bytes": 137678}]
{"company-data": {"conformed-name": "MEDICAL INTERNATIONAL TECHNOLOGY INC", "cik": "0001112372", "assigned-sic": "3841", "irs-number": "841509950", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-130695", "film-number": "051286037"}, "business-address": {"street1": "2281 GUENETTE", "street2": ".", "city": "VILLE SAINT-LAURENT", "state": "A8", "zip": "HR4 2E9", "phone": "(514) 339-9355"}, "mail-address": {"street1": "2281 GUENETTE", "street2": ".", "city": "VILLE SAINT-LAURENT", "state": "A8", "zip": "HR4 2E9"}, "former-company": {"former-conformed-name": "POSTERALLEY COM INC", "date-changed": "20000824"}}
-- Converted by SECPublisher 3.1.0.1, created by BCL Technologies Inc., for SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT under THE SECURITIES ACT OF 1933
Medical International Technology, Inc.
(Exact name of registrant as specified in charter)
Colorado
(State or other jurisdiction of incorporation or organization)
84-1509950
(IRS Employer Identification No.)
2281 Guenette, Ville Saint-Laurent Montreal, Quebec, Canada HR4 2E9
(Address of principal executive offices and Zip Code)
Compensation
(Full title of the plan)
Karim Menassa, 2281 Guenette, Montreal, Quebec, Canada HR4 2E9
(Name and address of agent for service)
(514) 339-9355
(Telephone number of agent for service)
CALCULATION OF REGISTRATION FEE
Proposed
Title of each class of
Proposed
Amount of
Amount to be
maximum
securities to be
maximum offering
registration
registered
aggregate offering
registered
price per share
fee
price
Common Shares
750,000
$0.40
$300,000
$
38.01
Note: Proposed maximum offering price per share and Proposed maximum aggregate offering price estimated solely for the purpose of calculating the registration fee pursuant to Rule 457.
PART I
INFORMATION REQUIRED IN THE PROSPECTUS
Note: The document(s) containing the information concerning the Medical International Technology Stock Option Agreement dated October 1, 2005, with Geoffrey Armstrong for services, to Medical International Technology, Inc.,
a Colorado corporation (the "Registrant" or the "Company"), required by Item 1 of Form S-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the statement of availability of registrant information, employee benefit plan
annual reports and other information required by Item 2 of Form S-8 will be sent or given to participants as specified in Rule 428. In accordance with Rule 428 and the requirements of Part I of Form S-8, such documents are not being filed with the
Securities and Exchange Commission (the "Commission") either as part of this registration statement on Form S-8 (the "Registration Statement") or as prospectuses or prospectus supplements pursuant to Rule 424. The Company will maintain a file of
such documents in accordance with the provisions of Rule 428. Upon request, the Company shall furnish to the Commission or its staff a copy or copies of all of the documents included in such file.
1
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which have been filed by the Company with the Securities and Exchange Commission, are hereby incorporated by reference:
a. The Company's Annual Report on Form 10-KSB for the fiscal year ended September 30, 2004;
b. The Company's Quarterly Reports on Form 10-QSB for the fiscal quarters ended December 31, 2004, March 31, 2005, June 30, 2005.
All documents filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective
amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated in this Registration Statement by reference and
to be a part hereof from the date of filing of such documents.
Any statement contained in this Registration Statement, in a supplement to this Registration Statement or in a document incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this
Registration Statement to the extent that a statement contained herein or in any subsequently filed supplement to this Registration Statement or in any document that is subsequently incorporated by reference herein modifies or supersedes such
statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4. Description of Securities.
The Company's authorized capital consists of 100,000,000 shares of Common Stock, $0.0001 par value and 3,000,000 shares of Preferred stock, par value $0.001, of which 9,341,435
common shares were outstanding as of December 9, 2005. No Preferred shares have been issued.
The Company's common stock is presently listed and traded on the NASD Over-The-Counter Bulletin Board exchange under the symbol "MDIR".
Common Stock
Each share of Common Stock is entitled to one vote, either in person or by proxy, on all matters that may be voted upon by the owners thereof at a meeting of the shareholders, including the election of directors. The
holders of Common Stock (i) have equal, ratable rights to dividends from funds legally available therefore, when, as and if declared by the Board of Directors of the Company; (ii) are entitled to share ratably in all of the assets of the Company
available for distribution to holders of Common Stock upon liquidation, dissolution or winding up of the affairs of the Company; (iii) do not have preemptive or redemption provisions applicable thereto; and (iv) are entitled to one non cumulative
vote per share on all matters on which shareholders may vote at all meetings of shareholders.
All shares of Common Stock issued and outstanding are, and those offered hereby, when issued, will be fully paid and nonassessable, with no personal liability attaching to the ownership thereof.
2
Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Road South, Suite 430
Denver, CO 80209
Item 5. Interests of Named Experts and Counsel.
As of the date of this registration no named expert or counsel holds any specified interest or significant equity in the company.
Item 6. Indemnification of Directors and Officers.
The Company's Articles of Incorporation authorizes the Corporation to indemnify to the maximum extent permitted under Colorado law.
The Colorado Private Corporations Act allows indemnification of directors, officers, employees and agents of the Company, including the advancement of expenses: Every person who was or is a party or is threatened to be made
a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or a person of whom he is the legal representative is or was a director or officer of the
corporation or is or was serving at the request of the corporation for its benefit as a director or officer of another corporation, or as its representative in a partnership, joint venture, trust or other enterprise, shall be indemnified and held
harmless to the fullest extent legally permissible under the general corporation law of the State of Colorado from time to time against all expenses, liability and loss (including attorney's fees, judgments, fines, and amounts paid or to be paid in
settlement) reasonably incurred and in advance of the final disposition of the action, suit or proceeding upon receipt of an undertaking by or on behalf of the director or officer to repay the amount if it is ultimately determined by a court of
competent jurisdiction that he is not entitled to be indemnified by the corporation. Such right of indemnification shall be a contract right which may be enforced in any manner desired by such person; and shall not be exclusive of any other right
which such directors, officers or representatives may have or hereafter acquire and, without limiting the generality of such statement, they shall be entitled to their respective rights of indemnification under any bylaw, agreement, vote of
stockholders, provision of law or otherwise, as well as their rights under the Articles of Incorporation of Medical International Technology, Inc..
In general, officers and directors of Registrant are indemnified against expenses actually and reasonably incurred in connection with proceedings, whether civil or criminal, provided that it is determined that they acted in
good faith, and are not deemed to be liable to Registrant for negligence or misconduct in the performance of their duties.
Item 7. Exemption from Registration Claimed.
Not Applicable.
3
Item 8. Exhibits.
Exhibit Number
Description
4.1
Medical International Technology Consulting Agreement with Kouzelne Mesto Ltd., a
Czech Republic Incorporated Company, beneficially owned as to 100% by Geoffrey
Armstrong, and dated October 1, 2005.
4.2
Medical International Technology Stock Option Agreement with Geoffrey Armstrong
dated October 1, 2005.
5.1
Opinion of Counsel, Dieterich & Associates
23.1
Consent of Certified Public Accountants
23.2
Consent of Dieterich & Associates (included in Exhibit 5.1)
Item 9. Undertakings
1.
The Registrant hereby undertakes:
(a) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(ii)to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the formation set forth in the registration statement;
(iii) to include any material information with respect to a plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
(b) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and
the offering of such securities at that time shall be deemed to be the initial bonafide offering thereof.
(c) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
2. The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange
Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement
relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be in the initial bona fide offering thereof.
4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Montreal, Quebec, Canada, on this 28th day of October, 2005.
Medical International Technology, Inc.
/s/ Karim Menassa
Karim Menassa
President and CEO
In accordance with the requirements of the Securities Act of 1933 as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
SIGNATURE
TITLE
DATE
/s/ Karim Menassa
Karim Menassa
Chief Executive Officer, President
December
9,
2005
/s/ Michel Bayouk
Michel Bayouk
Chief Financial Officer, Secretary
December
9,
2005
5